Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05927350 · ClinicalTrials.gov registry record
Research Participation With Transgender and Gender-Diverse Youth
A clinical trial of Transgender Persons, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT05927350: Recruiting study of Transgender Persons, sponsored by Virginia Commonwealth University.
NCT05927350 is a study of Transgender Persons that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 250 participants, above the 223-participant average among 3 other Transgender Persons trials with a reported enrollment target (12% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05927350, a study of Transgender Persons, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Research has historically excluded the participation of transgender and gender-diverse people. The purpose of this research study is to find out about what goes into a transgender and gender-diverse youth's decision to participate in research. The results of this study will be used to improve access to research for transgender and gender-diverse youth and therefore, improve the representation of transgender and gender-diverse youth as research participants in research.
Primary Outcome
The outcome will be the responses (agree or disagree) to the different items in the Pediatric Research Participation measure.
Conditions Studied
Interventions
- OTHER Survey
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-01-29 |
| Est. Completion | 2026-06 |
What NCT05927350 shows while recruiting
NCT05927350 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 223-participant average among 3 other Transgender Persons trials with a reported enrollment target (12% higher).
The record links to 1 condition, with Transgender Persons appearing as the primary indexed condition, and to 1 intervention - of which Survey is the first listed.
NCT05927350 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05927350 about?
NCT05927350 is a clinical study titled "Research Participation With Transgender and Gender-Diverse Youth". Research has historically excluded the participation of transgender and gender-diverse people. The purpose of this research study is to find out about what goes into a transgender and gender-diverse youth's decision to participate in research. The results of this study will be used to improve access...
What is the current status of trial NCT05927350?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-01-29. Estimated completion is 2026-06.
What conditions does trial NCT05927350 study?
This clinical trial studies the following conditions: Transgender Persons.
What interventions are being tested in trial NCT05927350?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT05927350?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05927350 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Transgender Persons
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TransHealthGUIDE: Transforming Health for Gender-Diverse Young Adults
RECRUITING · NA
-
Effect of Testosterone Treatment on Drug Metabolism and Transport
ACTIVE NOT RECRUITING
-
The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI